Viewing Study NCT06465732


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2026-05-22 @ 3:17 PM
Study NCT ID: NCT06465732
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-20
First Post: 2024-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords: